Kazia Therapeutics appoints Sudha Rao chief scientific officer
Share
Listen to the news
Kazia Therapeutics appoints Sudha Rao chief scientific officer
  • Kazia Therapeutics appointed Sudha Rao as chief scientific officer.
  • Rao will lead research and development as Kazia advances an integrated oncology platform strategy.
  • Rao leads Gene Regulation and Translational Medicine Laboratory at QIMR Berghofer Medical Research Institute.
  • She previously held senior scientific roles at Sanofi/Rhône-Poulenc in the UK.
  • Rao founded EpiAxis Therapeutics, serving as chief scientific officer.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kazia Therapeutics Limited published the original content used to generate this news brief via PR Newswire (Ref. ID: CN34715) on April 15, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending